Chubb Ltd

13F Filings History

Latest 13F report
Q4 2022 - Feb 3, 2023
Value $
$29.9M
Signature - Title
Annmarie Hagan - Chief Accounting Officer
Location
Zurich, Switzerland
Summary
This page shows a list of all the recent 13F filings made by Chubb Ltd. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Chubb Ltd reported 3 stock holdings with total value $29.9M as of Q4 2022. Top holdings included GRAB, NU, and PTCT.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q4 2022 3 $29.9M $0 $0 GRAB, NU, PTCT 13F-HR 2/3/2023, 12:09 PM
Q3 2022 3 $27M $0 $0 GRAB, NU, PTCT 13F-HR 11/4/2022, 10:02 AM
Q2 2022 3 $24.8M $0 -$285K -$285K GRAB, NU, PTCT 13F-HR 8/5/2022, 09:50 AM
Q1 2022 4 $40.2M +$17.7M $0 +$17.7M GRAB, NU, PTCT, NEWT 13F-HR 5/6/2022, 08:23 AM
Q4 2021 2 $45.6M +$45.2M $0 +$45.2M GRAB, PTCT 13F-HR 2/4/2022, 09:44 AM
Q3 2021 1 $304K $0 -$27.9M -$27.9M PTCT 13F-HR 11/8/2021, 03:16 PM
Q2 2021 3 $28.2M +$238K -$6M -$5.77M DCT, PTCT, NEWT 13F-HR 8/5/2021, 02:29 PM
Q1 2021 2 $35.3M $0 -$74.5M -$74.5M DCT, PTCT 13F-HR 5/5/2021, 10:02 AM
Q4 2020 3 $107M +$102M -$446K +$102M DCT, SNY, PTCT 13F-HR 2/5/2021, 04:36 PM
Q3 2020 3 $5.12M $0 -$22.7M -$22.7M SNY, PHR, PTCT 13F-HR 10/30/2020, 01:41 PM
Q2 2020 4 $28.1M +$4.44M $0 +$4.44M SNY, PHR, PTCT, NEWT 13F-HR 8/11/2020, 11:03 AM
Q1 2020 3 $20.3M +$3.41K $0 +$3.41K SNY, PTCT, NEWT 13F-HR 4/30/2020, 09:33 AM
Q4 2019 3 $23.4M +$4.6K $0 +$4.6K SNY, PTCT, NEWT 13F-HR 2/14/2020, 11:00 AM
Q3 2019 3 $21.5M +$3.5K $0 +$3.5K SNY, NEWT, PTCT 13F-HR 11/6/2019, 11:58 AM
Q2 2019 3 $20.2M $0 -$128M -$128M SNY, NEWT, PTCT 13F-HR 8/7/2019, 10:25 AM
Q1 2019 12 $149M +$10.6K -$2K +$8.64K MRK, SNY, BP, PFE, GSK 13F-HR 4/30/2019, 11:40 AM
Q4 2018 13 $138M +$3.01K -$742K -$739K MRK, SNY, PFE, TTE, GSK 13F-HR 2/8/2019, 10:07 AM
Q3 2018 14 $151M +$3.27K -$95.9M -$95.9M MRK, SNY, TTE, BP, PFE 13F-HR 10/31/2018, 11:51 AM
Q2 2018 21 $238M +$1.42M $0 +$1.42M MS, JPM, ADM, BP, MRK 13F-HR 7/27/2018, 10:17 AM
Q1 2018 20 $230M +$224K $0 +$224K MS, JPM, ADM, SNY, AZN 13F-HR 5/1/2018, 02:25 PM
Q4 2017 19 $230M +$9.72K -$934K -$924K MS, JPM, SNY, ADM, AZN 13F-HR 1/26/2018, 02:08 PM
Q3 2017 21 $229M $0 -$12.1M -$12.1M MS, SNY, MRK, ADM, JPM 13F-HR 10/27/2017, 10:18 AM
Q2 2017 21 $235M +$28.7K $0 +$28.7K MS, SNY, MRK, ADM, JPM 13F-HR 7/28/2017, 10:28 AM
Q1 2017 22 $232M +$137 -$2.08M -$2.08M MS, ADM, SNY, MRK, JPM 13F-HR 5/4/2017, 08:30 AM
Q4 2016 25 $228M +$1.02M -$77.5K +$942K MS, ADM, SNY, MRK, JPM 13F-HR 2/14/2017, 02:48 PM
Q3 2016 24 $221M +$1.81M -$22.1M -$20.3M ADM, MRK, GSK, SNY, AZN 13F-HR 11/14/2016, 05:49 PM
Q2 2016 27 $231M +$2.75M -$148M -$145M ADM, SNY, GSK, MRK, AZN 13F-HR 8/12/2016, 11:28 AM
Q1 2016 38 $367M $0 $0 SNY, BAC, C, AAL, ADM 13F-HR 5/13/2016, 10:35 AM